of gouty arthritis interleukin 1 inhibition in a novel animal model biomarkers of inflammation are suppressed by Hyperalgesia, synovitis and multiple

[1]  G. Yancopoulos,et al.  Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. , 2008, Arthritis and rheumatism.

[2]  D. Kastner,et al.  A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome. , 2008, Arthritis and rheumatism.

[3]  L. Sorkin,et al.  Effect of cytokines on neuronal excitability , 2008, Neuroscience Letters.

[4]  A. Murphy,et al.  Mice genetically deficient in neuromedin U receptor 2, but not neuromedin U receptor 1, have impaired nociceptive responses , 2007, PAIN.

[5]  J. Tschopp,et al.  A pilot study of IL-1 inhibition by anakinra in acute gout , 2007, Arthritis research & therapy.

[6]  P. Grieco,et al.  Melanocortin 3 receptors control crystal‐induced inflammation , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  S. Akira,et al.  MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. , 2006, The Journal of clinical investigation.

[8]  G. Nuki,et al.  A concise history of gout and hyperuricemia and their treatment , 2006, Arthritis research & therapy.

[9]  R. Terkeltaub,et al.  The inflammatory process of gout and its treatment , 2006, Arthritis research & therapy.

[10]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[11]  R. Liu-Bryan,et al.  Overview of hyperuricaemia and gout. , 2005, Current pharmaceutical design.

[12]  N. Dalbeth,et al.  Mechanisms of inflammation in gout. , 2005, Rheumatology.

[13]  R. Terkeltaub,et al.  Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. , 2005, Arthritis and rheumatism.

[14]  F. Martinon,et al.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.

[15]  G. Davies-Jones,et al.  Cytokine regulation of MCP-1 expression in brain and retinal microvascular endothelial cells , 2003, Journal of Neuroimmunology.

[16]  A. Bjartell,et al.  Expression and Production of the CXC Chemokine Growth-Related Oncogene-α by Human Eosinophils1 , 2003, The Journal of Immunology.

[17]  A. Matsukawa,et al.  Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[18]  B. Rovin,et al.  Role of protein kinase pathways in IL-1-induced chemoattractant expression by human mesangial cells. , 1994, Kidney international.

[19]  T. Morita,et al.  Micronucleus test with colchicine given by intraperitoneal injection and oral gavage. , 1989, Mutation research.

[20]  P. Wall,et al.  Ankle joint urate arthritis in rats provides a useful tool for the evaluation of analgesic and anti-arthritic agents , 1988, Pharmacology Biochemistry and Behavior.

[21]  J. Sipe,et al.  The acute phase response in gout. , 1987, The Journal of rheumatology.

[22]  S. Malawista,et al.  Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. , 1987, Journal of immunology.

[23]  P. Wall,et al.  Ankle joint urate arthritis (AJUA) in rats: an alternative animal model of arthritis to that produced by Freund's adjuvant , 1987, Pain.

[24]  S. Malawista,et al.  Crystal-induced endogenous pyrogen production. A further look at gouty inflammation. , 1985, Arthritis and rheumatism.

[25]  D. A. Willoughby,et al.  The formation of a structure with the features of synovial lining by subcutaneous injection of air: An in vivo tissue culture system , 1981, The Journal of pathology.

[26]  M. Zweig,et al.  Inhibition of sodium urate-induced rat hindpaw edema by colchicine derivatives: correlation with antimitotic activity. , 1972, Journal of Pharmacology and Experimental Therapeutics.

[27]  F. Martinon,et al.  Inflammatory caspases and inflammasomes: master switches of inflammation , 2007, Cell Death and Differentiation.

[28]  R. Terkeltaub.  Gout in 2006: the perfect storm. , 2006, Bulletin of the NYU hospital for joint diseases.

[29]  Scott Carver,et al.  Cytokine traps: multi-component, high-affinity blockers of cytokine action , 2003, Nature Medicine.